The Fact About ABBV-744 in combination with immunotherapy That No One Is Suggesting
In Segment C, members will receive ABBV-744 and oral navitoclax. In Section D, individuals will get ABBV-744 and ruxolitinib. Participants will obtain treatment until disease progression or perhaps the contributors are not able to tolerate the study drugs.Celastrol was discovered as a Myb inhibitor that suppressed C/EBPβ activity and repressed AML